Making Sense of the Latest News on the Chemical BPA

Making Sense of the Latest News on the Chemical BPA
The Nemours Foundation

You may be scratching your head about the highly controversial chemical bisphenol A (BPA), found in many everyday products (like plastic containers and the linings of some food and formula cans) — and for very good reason. A lot of this year's news about BPA has been just as conflicting as it is alarming.

Last month the U.S. Food and Drug Administration (FDA) came out with a draft report saying that the chemical is safe. But now, the National Toxicology Program (NTP), a fellow government agency that's part of the U.S. Dept. of Health and Human Services' National Institutes of Health, is officially declaring (after suggesting earlier this year) that BPA may not be safe. So, what's a worried parent to believe?

On the one hand, the current position of the FDA is that the miniscule amounts that leach into BPA-containing food containers aren't hazardous. According to a draft report by the FDA, "an adequate margin of safety exists for BPA at current levels of exposure from food contact uses, for infants and adults." But the FDA has not looked into how the chemical in other types of products may or may not have an effect.

On the other hand, the NTP released a finalized report after government scientists reviewed a draft of findings released in April of this year — that was the first federal U.S. report questioning the safety of the widely used chemical. In its official report the NTP says that "the possibility that human development may be altered by [BPA] at current expo?sure levels cannot be dismissed."

Specifically, the NTP report says there's:

  • "some concern" that BPA at "current human exposures" could cause effects in fetuses, babies, and children like behavioral and brain problems
  • "minimal concern" that BPA may cause early breast growth and puberty in girls
  • "negligible concern" that BPA exposure in moms-to-be can cause fetal or newborn deaths, birth defects, low birth weight, or growth problems in babies

The NTP's report is controversial because: 1) some of the report's recommendations differ from those of the FDA, and 2) its recommendations are based on data from studies done in animals, not in people. Animals metabolize BPA differently than humans and there's a lot of question about taking animal data and equating it with human risk.

One thing's for sure: Both the FDA and the NTP agree that more research is needed. The FDA will address the issue again when its draft report is reviewed by federal scientists, just as the NTP report was.

View Full Article

Add your own comment

Ask a Question

Have questions about this article or topic? Ask
Ask
150 Characters allowed

Today on Education.com